Clustering of cancer-related mutations in a subset of BRCA1 alleles:: A study in the Spanish population

被引:5
作者
de la Hoya, M
Sulleiro, S
Osorio, A
Díez, O
Baiget, M
Benítez, J
Díaz-Rubio, E
Caldés, T
机构
[1] Univ Madrid, Hosp San Carlos, Mol Oncol Lab, Madrid 28040, Spain
[2] Natl Canc Ctr, CNIO, Madrid, Spain
[3] Hosp Santa Creu I San Pau, Serv Genet, Barcelona, Spain
[4] Univ Madrid, Hosp San Carlos, Dept Med Oncol, Madrid 28040, Spain
关键词
BRCA1; D17S855; OR; CI; genetic testing; Spain;
D O I
10.1002/ijc.10527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have observed that the frequency of D17S855 short alleles (139 bp and 141 bp) in individuals carrying BRCA1 germline mutations is higher than in controls (54% vs. 31%, p = 0.0004). By unambiguously establishing mutation/D17S855 phase in 18 BRCA1-positive families, we find that most (11 of 15 different mutations) BRCA1 defects are linked to chromosomes with short alleles (OR = 8.21, 95% CI 1.97-39.32, p = 0.0007). We suggest that BRCA1 mutations are not randomly distributed but clustered in a subset of BRCA1 alleles that can be identified by D17S855 genotyping. Further analysis involving a larger set of mutations and different populations are needed to clarify the relevance of this unexpected finding. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:618 / 619
页数:2
相关论文
共 8 条
  • [1] HIGH-DENSITY GENETIC-MAP OF THE BRCA1 REGION OF CHROMOSOME-17Q12-Q21
    ANDERSON, LA
    FRIEDMAN, L
    OSBORNELAWRENCE, S
    LYNCH, E
    WEISSENBACH, J
    BOWCOCK, A
    KING, MC
    [J]. GENOMICS, 1993, 17 (03) : 618 - 623
  • [2] de la Hoya M, 2001, INT J CANCER, V91, P137, DOI 10.1002/1097-0215(20010101)91:1<137::AID-IJC1020>3.0.CO
  • [3] 2-R
  • [4] Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families:: Implications for genetic testing
    de la Hoya, M
    Osorio, A
    Godino, J
    Sulleiro, S
    Tosar, A
    Perez-Segura, P
    Fernandez, C
    Rodríguez, R
    Díaz-Rubio, E
    Benítez, J
    Devilee, P
    Caldés, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) : 466 - 471
  • [5] Díez O, 1999, INT J CANCER, V83, P465, DOI 10.1002/(SICI)1097-0215(19991112)83:4<465::AID-IJC5>3.0.CO
  • [6] 2-4
  • [7] A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1
    MIKI, Y
    SWENSEN, J
    SHATTUCKEIDENS, D
    FUTREAL, PA
    HARSHMAN, K
    TAVTIGIAN, S
    LIU, QY
    COCHRAN, C
    BENNETT, LM
    DING, W
    BELL, R
    ROSENTHAL, J
    HUSSEY, C
    TRAN, T
    MCCLURE, M
    FRYE, C
    HATTIER, T
    PHELPS, R
    HAUGENSTRANO, A
    KATCHER, H
    YAKUMO, K
    GHOLAMI, Z
    SHAFFER, D
    STONE, S
    BAYER, S
    WRAY, C
    BOGDEN, R
    DAYANANTH, P
    WARD, J
    TONIN, P
    NAROD, S
    BRISTOW, PK
    NORRIS, FH
    HELVERING, L
    MORRISON, P
    ROSTECK, P
    LAI, M
    BARRETT, JC
    LEWIS, C
    NEUHAUSEN, S
    CANNONALBRIGHT, L
    GOLDGAR, D
    WISEMAN, R
    KAMB, A
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 266 (5182) : 66 - 71
  • [8] Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
    Osorio, A
    Barroso, A
    Martínez, B
    Cebrián, A
    San Román, JM
    Lobo, F
    Robledo, M
    Benítez, J
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (07) : 1266 - 1270